Pill Identifier App

Clinical Trials Update: March 7, 2008

-- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Multiple Sclerosis

If you are aged 18 to 55, have multiple sclerosis with at least one relapse during the past year, are able to walk without aid or rest more than 100 meters, and have failed treatment with a beta-interferon, you may qualify for this study.

The research site is in Lenexa, Kansas.

More information

Please see http://www.centerwatch.com/patient/studies/cat102.html.


Moyamoya Syndrome

If you are 18 or older and capable of informed consent, you may qualify for this study. Both asymptomatic and symptomatic patients with moyamoya will be included.

The research site is in St. Louis, Mo.

More information

Please see http://www.centerwatch.com/patient/studies/cat652.html.


Pancreatic Cancer

If you are 18 or older; have unresectable, locally advanced adenocarcinoma of the pancreas proven by biopsy or cytology; have not been treated for pancreatic cancer; and have a life expectancy greater than three months, you may qualify for this study.

The research site is in Greenville, N.C.

More information

Please see http://www.centerwatch.com/patient/studies/cat35.html.


Copyright 2008 CenterWatch. All rights reserved.

Posted: March 2008

View comments